Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04489173
Title TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer (TIBET)
Acronym TIBET
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Borstkanker Onderzoek Groep
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD

Facility Status City State Zip Country Details
Rijnstate Arnhem Netherlands Details
Wilhelmina ziekenhuis Assen Netherlands Details
Amphia Ziekenhuis Breda Netherlands Details
Reinier de Graaf Groep Delft Netherlands Details
Deventer ziekenhuis Deventer Netherlands Details
Catharina Ziekenhuis Eindhoven Netherlands Details
MC Leeuwarden Leeuwarden Netherlands Details
MUMC Maastricht Netherlands Details
Erasmus MC Rotterdam Netherlands Details
UMC Utrecht Utrecht Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field